GNLX short interest
Genelux Corporation · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,362,110 |
|---|---|
| Change vs prior report | 265,825 (+6.5%) |
| Change over six months | +39.1% |
| Days to cover | 20.43 (sector: 3.78) |
| Average daily volume | 213,487 |
| Rank in Healthcare | #16 of 922 by days to cover |
GNLX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,362,110 | +6.5% | 20.43 | 213,487 |
| 2026-09-15 | 4,096,285 | +8.5% | 14.41 | 284,331 |
| 2026-08-31 | 3,775,663 | +7.3% | 10.65 | 354,595 |
| 2026-08-14 | 3,517,862 | +14.1% | 8.45 | 416,184 |
| 2026-07-31 | 3,083,334 | -1.0% | 20.15 | 152,999 |
| 2026-07-15 | 3,113,408 | +3.5% | 17.89 | 174,004 |
| 2026-06-30 | 3,007,000 | -5.5% | 12.81 | 234,814 |
| 2026-06-15 | 3,183,715 | +1.5% | 20.93 | 152,094 |
| 2026-05-29 | 3,136,753 | +6.0% | 23.95 | 130,952 |
| 2026-05-15 | 2,958,061 | -6.0% | 15.08 | 196,173 |
| 2026-04-30 | 3,148,462 | +4.2% | 24.28 | 129,672 |
| 2026-04-15 | 3,020,978 | -3.7% | 10.48 | 288,377 |
| 2026-03-31 | 3,135,864 | +9.9% | 15.03 | 208,627 |
| 2026-03-13 | 2,852,181 | -3.7% | 18.80 | 151,697 |
| 2026-02-27 | 2,962,542 | -4.7% | 23.52 | 125,961 |
| 2026-02-13 | 3,108,498 | -1.5% | 13.67 | 227,355 |
| 2026-01-30 | 3,157,173 | +3.1% | 13.31 | 237,121 |
| 2026-01-15 | 3,061,275 | +1.2% | 5.73 | 533,804 |
| 2025-12-31 | 3,024,926 | -1.8% | 31.33 | 96,543 |
| 2025-12-15 | 3,080,437 | +5.2% | 18.01 | 171,035 |
| 2025-11-28 | 2,928,259 | -0.9% | 15.59 | 187,833 |
| 2025-11-14 | 2,953,521 | +23.2% | 7.21 | 409,565 |
| 2025-10-31 | 2,397,899 | +8.4% | 8.39 | 285,836 |
| 2025-10-15 | 2,212,278 | +0.2% | 14.94 | 148,081 |
| 2025-09-30 | 2,207,744 | +1.9% | 15.45 | 142,889 |
import finzdata as yf
yf.Ticker("GNLX").short_interest # every report since 2017
yf.Client().short_interest(["GNLX"], start="2018-01-01")Healthcare short interest · GNLX price history · Who owns GNLX · All short interest